Interferon alphaB (human leucocyte protein moiety reduced) is a naturally occurring protein that is produced by the body in response to viral infections and immune system challenges. It is a key component of the immune response, enhancing the body's ability to fight off infections and inhibiting the replication of viruses. This specific form of interferon has a reduced moiety, which means it has a smaller molecular group, potentially making it more effective and better tolerated by the body. It is administered via injection and is an important tool in the treatment of viral infections and certain cancers.
77238-31-4
Post Buying Request-
-
Basic information
- Product Name: Interferon alphaB (human leucocyte protein moiety reduced)
- Synonyms: Interferon alphaB (human leucocyte protein moiety reduced)
- CAS NO:77238-31-4
- Molecular Formula:
- Molecular Weight: 0
- EINECS: N/A
- Product Categories: N/A
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: N/A
- Refractive Index: N/A
- Storage Temp.: N/A
- Solubility: N/A
- CAS DataBase Reference: Interferon alphaB (human leucocyte protein moiety reduced)(CAS DataBase Reference)
- NIST Chemistry Reference: Interferon alphaB (human leucocyte protein moiety reduced)(77238-31-4)
- EPA Substance Registry System: Interferon alphaB (human leucocyte protein moiety reduced)(77238-31-4)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 77238-31-4(Hazardous Substances Data)
77238-31-4 Suppliers
Recommended suppliers
77238-31-4 Usage
Uses
Used in Viral Infection Treatment:Interferon alphaB (human leucocyte protein moiety reduced) is used as an antiviral agent for the treatment of conditions such as hepatitis B and C. It boosts the body's immune response, helping to control the spread of infection and aiding in the clearance of the virus from the body.
Used in Cancer Treatment:
Interferon alphaB (human leucocyte protein moiety reduced) is used as an immunotherapeutic agent for the treatment of certain types of cancer, including leukemia. It enhances the body's immune response to cancer cells, inhibiting their growth and spread.
Used in Pharmaceutical Industry:
Interferon alphaB (human leucocyte protein moiety reduced) is used as a therapeutic protein in the pharmaceutical industry for the treatment of viral infections and certain cancers. Its reduced moiety makes it potentially more effective and better tolerated by the body, offering a valuable alternative to other forms of interferon.
Used in Research Applications:
Interferon alphaB (human leucocyte protein moiety reduced) is used as a research tool in the study of immune system responses to viral infections and cancer. Its role in enhancing the body's immune response and inhibiting viral replication makes it a valuable asset in understanding the mechanisms of the immune system and developing new treatments for viral infections and cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 77238-31-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,2,3 and 8 respectively; the second part has 2 digits, 3 and 1 respectively.Calculate Digit Verification of CAS Registry Number 77238-31:
(7*7)+(6*7)+(5*2)+(4*3)+(3*8)+(2*3)+(1*1)=144
144 % 10 = 4
So 77238-31-4 is a valid CAS Registry Number.
77238-31-4Upstream product
77238-31-4Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 77238-31-4
Interferon alphaB (human leucocyte protein moiety reduced)
